Exocrine Pancreatic Insufficiency
52
7
7
33
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Published Results
19 trials with published results (37%)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
5.8%
3 terminated out of 52 trials
91.7%
+5.2% vs benchmark
40%
21 trials in Phase 3/4
58%
19 of 33 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 33 completed trials
Clinical Trials (52)
A Study Of Effect Of Secretin For In Injection (Chirostim) On Pancreatic Fluid Composition In Healthy Subjects
Phase 1 Study to Assess Safety and Efficacy of ANG003
Malabsorption Blood Test (MBT) to Determine Exocrine Pancreatic Function and Related Quality of Life in Chronic Pancreatitis
Evaluating the Utility of RELiZORB™ for Treating Feeding Intolerance in Critically Ill Adults With Multi-Organ Failure
Role of Pancreatic Exocrine Secretion in Weight Gain After Pancreas Transplantation
Pancreatic Enzyme Replacement Therapy for Acute Pancreatitis-Associated Exocrine Pancreatic Insufficiency
Exocrine Pancreatic Insufficiency and Functional Dyspepsia
Fatty Liver and Pancreatic Steatosis
Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform
BÜHLMANN FPELA in the Diagnosis of Exocrine Pancreatic Insufficiency
Oral CDX-7108 in Healthy Adults and EPI Subjects
Study to Assess an Enteric Microgranule Formulation of Adrulipase in Patients With Cystic Fibrosis
Investigating Predictive Factors of Diabetes Occurence After Duodenalpancreatectomy
AI Evaluation of Pancreatic Exocrine Insufficiency in CP Patients
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Exocrine Pancreatic Dysfunction in Type 1 Diabetes
Pancreatic Exocrine Insufficiency in Acute Pancreatitis
Exocrine Pancreatic Insufficiency After Acute Pancreatitis and Pancreatic Enzyme Replacement Therapy
Registry of Pancreatic Exocrine Insufficiency.
Special Investigation of LipaCreon on Long-term Use in Patients With Pancreatic Exocrine Insufficiency
Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis